Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 18, 2023 - Issue
Submit an article Journal homepage
446
Views
7
CrossRef citations to date
0
Altmetric
REVIEW

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease

Wenwen Wang1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Aihua Mei1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Hang Qian1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Dongfeng Li1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Hao Xu1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Jishun Chen1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Handong Yang1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Xinwen Min1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Chunlei Li1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Li Cheng1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
&
Jun Chen1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of China;2 Institute of Virology, Hubei University of Medicine, Shiyan, Hubei, 442000, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-9071-2436View further author information
ORCID Icon show all
Pages 129-137 | Received 13 Oct 2022, Accepted 02 Feb 2023, Published online: 15 Feb 2023

Figures & data

Figure 1 The GLP-1/GLP-1R signaling pathway in cells.

Figure 1 The GLP-1/GLP-1R signaling pathway in cells.

Figure 2 Effect of GLP-1/GLP-1RA on COPD through different pathways. ↑: indicates an increase ↓: indicates a decrease.

Figure 2 Effect of GLP-1/GLP-1RA on COPD through different pathways. ↑: indicates an increase ↓: indicates a decrease.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.